Parkside Financial Bank & Trust’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Parkside Financial Bank & Trust's ORGO Position: Q2 2026 in Review
Parkside Financial Bank & Trust opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 285 shares worth $693. The stake represents ﹤0.01% of the portfolio and ranks #2530 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in ORGO as recently as Q4 2022.
Parkside Financial Bank & Trust first reported a position in ORGO in Q3 2021 and has held it in 5 quarters since. The position peaked at $3K in Q4 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Parkside Financial Bank & Trust held 285 shares of Organogenesis Holdings worth $693 as of Q2 2026.
- Organogenesis Holdings was a new Parkside Financial Bank & Trust position in Q2 2026.
- Organogenesis Holdings made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2530 holding.
- Parkside Financial Bank & Trust first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 5 quarters since.
- Parkside Financial Bank & Trust's Organogenesis Holdings position peaked at $3K in Q4 2021.
- 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.